Redeye comments on Imint’s Q4 2022 report, which came in weaker than expected, both in terms of sale...
Redeye sees a report that continues to show strong sales development.
Redeye comments on Embracers Groups multi-year agreement with New Line Cinema and Warner Bros regard...
EBITDA -13% vs ABGSCe Guides for at least 10% ACV growth We expect cons.
Redeye leaves its comments on InDex following the company’s Q4 report.
As 2022 ended on a high note for Motion Display, with deals signed in the USA, Germany and Australia...
Redeye notes a quarter showing continuing sales growth for AroCell with good cost control.
In the fourth quarter, Cantargia continued with its ongoing programs and strategy.
Redeye comments on Vitec acquiring the Dutch VMS company Enova, which offers energy-management softw...
Redeye updates its estimates and fair value range following Westpay’s Q4 report.
Cibus's Q4 2022 income from property management (IFPM) was below consensus, even when adjusted for E...
Boreo will report its Q4 2022 on 3 March 2023. We take a slightly more cautious view, owing to a slo...
Raising estimates by 7-21%. Raised order intake, sales and earnings New strategy, as expected.
Bricknode published on February 23 the company’s quarterly report for the fourth quarter 2022.
Q4: Impressive profitability, EBIT margin of 13.1% (10.
Redeye comments on the launch of Sleep Cycle Kids, an app providing parents with tools to optimize t...
Zoomability publicerade den 23 februari 2023 bolagets delårsrapport för årets fjärde kvartal och vis...
Duearity publicerade den 23 februari bolagets delårsrapport för Q4-22 och visar på fortsatt framsteg...
Redeye updates its estimates following Freemelt’s Q4 report, which came in lower than expected due t...
STENOCARE published on February 23 its year end report for 2022.
